EAU 2013 - Programme Book - YouMed

239 The unattainability of bladder cancer biomarkers: Utility-based assessment of a hypothetical non-invasive
surveillance tool for bladder cancer recurrence
D. Nekeman, L.J. Billingham, N.K. Aaronson, N.D. James, K.K. Cheng, R.T. Bryan, M.P.A. Zeegers
(Birmingham, United Kingdom; Amsterdam, The Netherlands)
240 The ADC value is a prognostic biomarker of upper urinary tract cancer: Potential application to
preoperative risk stratification
S. Yoshida, S. Kobayashi, F. Koga, J. Ishioka, C. Ishii, H. Tanaka, Y. Nakanishi, Y. Matsuoka, N. Numao,
K. Saito, H. Masuda, Y. Fujii, K. Kihara (Tokyo, Japan)
241 Preoperativ serum C-reactive protein: A prognostic marker in patients with upper urinary tract urothelial
carcinoma
B. Stein, A.J. Schrader, G. Wegener, C. Seidel, M.A. Kuczyk, S. Steffens (Hanover, Ulm, Germany)
242 The predictive value of C-reactive protein on prognosis of patients with upper tract urothelial carcinoma
treated with radical nephroureterectomy: Multi-institutional study
E. Kikuchi, N. Tanaka, S. Shirotake, K. Matsumoto, H. Kobayashi, Y. Miyazaki, H. Ide, J. Obata, K. Hoshino,
N. Hayakawa, Y. Ito, K. Kanao, A. Miyajima, T. Momma, K. Nakagawa, M. Ueno, M. Oya (Tokyo, Saitama,
Japan)
EAU Milan 2013
137
Saturday